Skip to main content

WEX Inc.

For the period ended Jun 30, 2026. Filed Jul 23, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Jul 23, 2026

WEX$182.53+0.2%Stored close · as of Nov 9, 2026

What changed in Risk Factors?

Read the current filing

Previous report: 10-Q

Period ended 2026-03-31; filed 2026-04-23.

0001309108-26-000017

Item 1A. Risk FactorsUnregistered Sales of Equity Securities and Use of Proceeds

Current report: 10-Q

Period ended 2026-06-30; filed 2026-07-23.

0001309108-26-000029

Item 1A. Risk FactorsUnregistered Sales of Equity Securities and Use of Proceeds

The baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.

Compared 3 previous paragraphs and 5 current paragraphs.

2 unchanged; 1 reworded; 2 added; 0 removed; 0 previous and 0 current paragraphs rearranged.

Tables are not compared: 0 previous and 1 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.

A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.

Added paragraphs (2)

Current report

The Company had the following common stock repurchases under share repurchase programs during the second quarter of 2026.

Current report

(2) The Inflation Reduction Act of 2022, which was enacted into law on August 16, 2022, imposed a nondeductible one percent excise tax on the net value of certain stock repurchases. All dollar amounts presented excludes such excise tax, as applicable.
Reworded paragraphs (1)

Previous wording

Under a share repurchase plan approved by our board of directors and announced on September 9, 2024, the Company was authorized to repurchase up to a total of $2.05 billion worth of its common stock through open market purchases, privately negotiated transactions, accelerated share repurchase programs, issuer self-tender offers or other means pursuant to the share repurchase plan, through December 31, 2025. On January 1, 2026, the then existing share repurchase plan expired without extension or renewal. Accordingly, the Company had no common stock repurchases during the first quarter of 2026.

Current wording

(1 )Under a share repurchase program authorization, approved by our board of directors and announced on May 14, 2026, the Company is authorized to repurchase up to a total of $1.0 billion worth of its common stock through open market purchases, privately negotiated transactions, accelerated share repurchase programs, issuer self-tender offers or other means pursuant to the share repurchase program. The share repurchase program authorization has no expiration date.